Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
about
Antiviral agents for hepatitis B virus-related cirrhosisRadiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosisReview of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog TherapyManagement of HBV and HBV/HDV-Associated Liver CirrhosisEvaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-AnalysisNatural regression of fibrosis in chronic hepatitis BKASL clinical practice guidelines: management of chronic hepatitis BClinical applications, limitations and future role of transient elastography in the management of liver disease.Treatment strategies for chronic hepatitis C prior to and following liver transplantationThe Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide AnalogsUpdate on Hepatitis B Virus Infection: Focus on TreatmentBenefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosisManagement of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinomaPrediction of fibrosis progression in chronic viral hepatitisDoes antiviral therapy reduce complications of cirrhosis?Application of nucleoside analogues to liver transplant recipients with hepatitis BOutcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factorsCellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosisDirect acting antivirals for the treatment of chronic viral hepatitisPrevention of hepatocellular carcinoma in patients with chronic hepatitis BNucleoside/nucleotide analogues in the treatment of chronic hepatitis BMolecular mechanism and treatment of viral hepatitis-related liver fibrosis.Treatment strategies according to genotype for chronic hepatitis B in childrenEvaluation of liver fibrosis: "Something old, something new…"Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver diseaseHGF and direct mesenchymal stem cells contact synergize to inhibit hepatic stellate cells activation through TLR4/NF-kB pathwayA novel estimation of the relative economic value in terms of different chronic hepatitis B treatment optionsCurrent role of transient elastography in the management of chronic hepatitis B patientsDiagnostic Accuracy of Acoustic Radiation Force Impulse (ARFI) in Diagnosis of Liver Fibrosis among Egyptian Patients with Chronic HCV InfectionComparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and CUse of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B VirusAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Assessment of hepatic fibrosis regression by transient elastography in patients with chronic hepatitis B treated with oral antiviral agentsA serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.Non-invasive markers for hepatic fibrosisCurrent hepatitis B treatment guidelines and future research directions.Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.Role of NADPH oxidases in liver fibrosis.A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese.Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.
P2860
Q24200681-0F82B154-982B-43FE-A6FC-448B0BFDA080Q26738533-EB3854D8-A30D-4708-A650-59D2FB020C78Q26740161-B3B47504-D089-415A-8857-060DA9664D9DQ26740323-57F5196A-173F-4FFA-9865-EBD8CBC9E32BQ26742104-EA1AB15C-18AD-43A0-8442-18D59F1870A9Q26746929-8C34523A-21D9-494B-8FC3-F5041EC4860DQ26752475-62DC71D4-F87B-42F4-9D06-CECB03B655F3Q26768262-09510F1D-BA6C-44F5-B816-183EC3E1CC7EQ26771244-9F7AD2E5-C04D-4FFF-9DC1-796F502F2CE3Q26781795-7014C874-BF21-42B9-B13A-AEEC0147E7ACQ26781990-8AF06478-73DE-44D8-A8E9-A5B6F97C7425Q26783356-B479EE24-602F-434A-B0E0-2CFC0AE886E5Q26799056-D99DA99E-A0E6-41D3-AB45-3735A488381BQ26823671-CBF6EB92-A507-4C88-BB93-9DCA8724D105Q26851410-03B1B94B-40F8-4A15-890E-B20C02B9D0B3Q26859796-FB280464-DACB-4680-9DBB-E37A213C8720Q27020938-DA204EB4-9D11-4AA5-86BC-70D24ABE5851Q27021577-C5106D99-D5F9-4EC0-828D-A64C6D2C86EAQ27022216-13BEDFB2-CE28-465A-AD48-C7907917E297Q27023997-9A43CE6A-1EF1-4577-8DA3-4B628138EC9EQ27030828-4155A6D1-A378-4E9C-84C5-D83E4677288CQ27692609-8EC12475-A2CF-4801-86B4-8EFB56A14F4CQ28066476-7715BACD-6A02-4D03-A27A-0056581C9EE1Q28068532-47DA1E0C-828B-4F6B-8175-B8BF44D3157BQ28088566-4D6A2D3B-E062-438A-8EB1-768A73C467F6Q28482499-23D9E899-E006-43A8-A0EF-C7F41078EA58Q28704122-519CBCE1-FD87-454D-9E2A-CB0B942318C0Q30358894-C611F593-86BC-45F2-8A5D-E7FD87DAC165Q30372945-9A5E2159-2A20-4FEF-A79D-674404838085Q30374701-3F7C0779-242F-4744-A840-5879B2BCAA1EQ30375738-ED16DA41-EAE1-4F67-8239-41F38A32FEE0Q30391932-6D4D3C52-67D6-4D86-A2A8-32E5C490D7EAQ30439873-C8340EEA-2FDD-414D-9294-88CFDF377A6DQ30459124-5D4640FB-EF19-48DC-9B87-EE2A515EB17EQ30474093-ED9F5CC8-3B2B-4634-AE0A-C3AA256403ACQ30487002-26F9C88A-4928-4457-8540-1354F872B012Q30829485-3DCFD5AD-3145-4766-B1EA-FEC700B937B9Q33632736-84F4BEC8-7DD9-4930-AA88-6A06B614D6F5Q33773772-8F4E4662-46BF-4A59-BED2-0630944265D6Q33787655-6C0AD6DD-11E5-41F7-9D2E-8993248E4E69
P2860
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Long-term entecavir therapy re ...... ents with chronic hepatitis B.
@en
Long-term entecavir therapy re ...... ents with chronic hepatitis B.
@nl
type
label
Long-term entecavir therapy re ...... ents with chronic hepatitis B.
@en
Long-term entecavir therapy re ...... ents with chronic hepatitis B.
@nl
prefLabel
Long-term entecavir therapy re ...... ents with chronic hepatitis B.
@en
Long-term entecavir therapy re ...... ents with chronic hepatitis B.
@nl
P2093
P2860
P50
P356
P1433
P1476
Long-term entecavir therapy re ...... ents with chronic hepatitis B.
@en
P2093
Bruce Kreter
Eugene Schiff
Kwang-Hyub Han
Rifaat Safadi
Robert Hindes
Samuel S Lee
Shun-Sheng Wu
Suzanne Beebe
Ting-Tsung Chang
P2860
P304
P356
10.1002/HEP.23785
P407
P577
2010-09-01T00:00:00Z